Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.64 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | STAT6 | P42226 | 1/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL173508 | 1.00 | HSD17B10 (0.64) | HSD17B10SLC6A9ALDH1A1SMN1; SMN2STAT6 | |
| SCHEMBL321989 | 1.00 | HSD17B10 (0.64) | HSD17B10SLC6A9ALDH1A1SMN1; SMN2STAT6 | |
| SCHEMBL3660521 | 1.00 | — | — | |
| Tetraxetan SCHEMBL2017956 | 1.00 | HSD17B10 (0.64) | HSD17B10SLC6A9ALDH1A1SMN1; SMN2STAT6 | |
| SCHEMBL6848102 | 1.00 | HSD17B10 (0.64) | HSD17B10SLC6A9ALDH1A1SMN1; SMN2STAT6 | |
| SCHEMBL6744121 | 1.00 | HSD17B10 (0.64) | HSD17B10SLC6A9ALDH1A1SMN1; SMN2STAT6 | |
| SCHEMBL3503521 | 1.00 | HSD17B10 (0.64) | HSD17B10SLC6A9ALDH1A1SMN1; SMN2STAT6 | |
| Tetraxetan SCHEMBL2635294 | 1.00 | HSD17B10 (0.64) | HSD17B10SLC6A9ALDH1A1SMN1; SMN2STAT6 | |
| Tetraxetan SCHEMBL23647851 | 0.97 | HSD17B10 (0.61) | HSD17B10SLC6A9ALDH1A1SMN1; SMN2STAT6 | |
| Tetraxetan SCHEMBL15766009 | 0.97 | HSD17B10 (0.61) | HSD17B10SLC6A9ALDH1A1SMN1; SMN2STAT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 45693 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146088-A1 | ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE | GENENTECH, INC. (US) | 2026-05-28 | — | — | US | claimed |
| CN-118470398-B | Directed target detection method based on hierarchical mask prompt and robust integrated regression | NORTHWESTERN POLYTECHNICAL UNIVERSITY (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-122094950-A | Ligand compound with quinoline structure, and radioactive or non-radioactive marker and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122080126-A | PD-L1 targeting polypeptide, conjugate and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122094718-A | Image-guided biopsy of HER2 positive lesions | — | 2026-05-26 | — | — | CN | claimed |
| CN-122074048-A | Methods of treating cancer | 诺华股份有限公司 | 2026-05-22 | — | — | CN | claimed |
| WO-2026106998-A1 | PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-TARGETED POLY(ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR AND RELATED COMPOSITION AND METHOD OF USE | PURDUE RESEARCH FOUNDATION (US) | 2026-05-21 | — | — | WO | claimed |
| WO-2026103789-A1 | METHOD FOR PREPARING LUTETIUM[177LU]DOTATATE AND PRECURSOR COMPOUND THEREOF | 迈得诺医疗科技集团有限公司 | 2026-05-21 | — | — | WO | claimed |
| US-20260137819-A1 | FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY INC (US) | 2026-05-21 | — | — | US | claimed |
| US-20260137821-A1 | PEPTIDE STRUCTURE TARGETING CARBONIC DEHYDROGENASE IX AND USE THEREOF | C-BIOMEX CO., LTD. (KR) | 2026-05-21 | — | — | US | claimed |
| EP-0270483-A2 | Pharmaceutical compounds containing metals | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-06-08 | — | — | EP | claimed |
| EP-0247156-A1 | POLYCHELATING AGENTS FOR IMAGE AND SPECTRAL ENHANCEMENT (AND SPECTRAL SHIFT). | UNIV TEXAS (US) | 1987-12-02 | — | — | EP | claimed |
| US-4678667-A | DIAGNOSIS AND THERAPY OF TUMORS | 501 Regents of the University of California (US) | 1987-07-07 | — | — | US | claimed |
| WO-1987002893-A1 | POLYCHELATING AGENTS FOR IMAGE AND SPECTRAL ENHANCEMENT (AND SPECTRAL SHIFT) | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1987-05-21 | — | — | WO | claimed |
| US-4639365-A | Gadolinium chelates as NMR contrast agents | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1987-01-27 | — | — | US | claimed |
| EP-0198051-A1 | GADOLINIUM CHELATES AS NMR CONTRAST AGENTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1986-10-22 | — | — | EP | claimed |
| WO-1986002352-A1 | GADOLINIUM CHELATES AS NMR CONTRAST AGENTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1986-04-24 | — | — | WO | claimed |
| US-4508625-A | NEGATIVELY CHARGED SURFACE OF PARTICLES HAVING INCREASED MAGNETIC SUSCEPTIBILITY | COULTER INTERNATIONAL CORP. | 1985-04-02 | — | — | US | claimed |
| EP-0124579-A1 | MAGNETIC SEPARATION USING CHELATED MAGNETIC IONS | COULTER ELECTRONICS INC. (US) | 1984-11-14 | — | — | EP | claimed |
| WO-1984001503-A1 | MAGNETIC SEPARATION USING CHELATED MAGNETIC IONS | COULTER ELECTRONICS (US) | 1984-04-26 | — | — | WO | claimed |